Interestingly, in a previous edition of the JCI, Silver et al. demonstrated that CTH inhibition resulted in substantial GSC enrichment, increased tumor cell proliferation, and protection from necrotic cell death (18), all of which help to explain why overall survival was not improved with CTH knockdown. The gene discussed is CTH; the disease is neoplasm.